Researcher

Yue Yang

Gynecology Department, Changxing Maternal and Child Health Hospital, Huzhou, China.

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy

Biomarker Research

Preclinical mechanistic study in transgenic mice and PDX models with a novel protein delivery approach; no clinical efficacy data or human trials reported, only mechanism validation and proof-of-concept in xenografts.

PreliminaryYue Yang Pi3k/akt/mtor Signaling in Cancer Cancer Cells and Metastasis

Study details

DesignPreclinical mechanistic study in transgenic…

InterventionTargeted RBM38 expression in breast tissue;…

ComparatorDoxorubicin co-administration (for cardioto…

JUL 8, 2026 · JOURNAL ARTICLE

Post-vaccination HPV prevalence, genotype distribution, and associated factors among vaccinated women in China: A cross-sectional study.

Human Vaccines & Immunotherapeutics

Cross-sectional study with 893 participants demonstrates reduced post-vaccination HPV prevalence and identifies expected risk factors, reinforcing established vaccination strategies.

Important Confirmatory EvidenceYue Yang Yulong Liang Papillomavirus Infections

Reported

Sample size893

Post-vaccination HPV prevalence8.51%

AOR age ≥40y2.92